Levemir Flexpen Injection 100 IU 5 Pre filled Penx3 mL

Frequently asked questions

• Onset of action

  The effect of this medicine can be observed within 3-4 hours of administration of dose.

• Duration of Effect

  The effect of this medicine lasts for an average duration of 24 hours.

• Safe with Alchohol?

  Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of both hypoglycemia (low blood glucose levels) and hyperglycemia (high blood glucose levels) depending on the quantity and frequency of alcohol consumption. This may cause severe side effects such as dizziness, drowsiness, increased thirst, increased hunger, mood changes, extreme fatigue, etc.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is considered safe for use by pregnant women. However, it must be used only when necessary and the potential benefits outweigh the risks.

• Usage while breast-feeding?

  Use of insulin by breastfeeding women is considered acceptable. All the risks and benefits should be discussed with the doctor before using this medicine. Breastfeeding women generally require lower doses of insulin.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to Levemir Flexpen Injection 100 IU 5 Pre filled Penx3 mL or any other inactive ingredients present along with it.

• Hypoglycemia

  This medicine is not recommended for use in patients suffering from decreased blood sugar levels (hypoglycemia) since it may worsen the patient's condition.

• Pregnancy

  This medicine is considered safe for use by pregnant women. However, it must be used only when necessary and the potential benefits outweigh the risks.

• Breast-feeding

  Use of insulin by breastfeeding women is considered acceptable. All the risks and benefits should be discussed with the doctor before using this medicine. Breastfeeding women generally require lower doses of insulin.

• Diabetic Ketoacidosis

  This medicine is not recommended for the treatment of diabetic ketoacidosis due to the delayed onset of action. Alternative treatment options should be considered based on the clinical condition of the patient.

• Hypersensitivity reactions

  This medicine may cause serious and occasionally fatal hypersensitivity reactions (severe allergic reactions) including anaphylactic shock in some patients. Seek immediate medical intervention if any signs and symptoms of an allergic reaction such as skin rash, sore throat, difficulty breathing, swelling of the face, etc. occur. If an anaphylactic reaction occurs, the treatment should be discontinued immediately and appropriate corrective measures should be undertaken.

• Hypoglycemia

  This medicine may cause hypoglycemia (low blood glucose levels) in some patients. This risk is especially higher in patients suffering from kidney diseases, malnourishment, pituitary gland diseases, etc. Close monitoring of blood glucose levels is recommended for such patients. Appropriate dose adjustments may be required based on the clinical condition. Your doctor may advise you to carry a sugar candy to counteract the effects of low blood sugar levels (hypoglycemia).

• Hypokalemia (Decreased potassium levels)

  Hypokalemia (Decreased potassium levels)

• Use in children

  This medicine is not recommended to use in children below 1 year of age since the safety and efficacy of use are not clinically established.

• Subcutaneous use only

  This medicine is meant for subcutaneous administration only. The long duration of action of this medicine is dependent on a subcutaneous administration. It should not be administered intravenously or intramuscularly.

• Heart failure

  This medicine should be used with extreme caution in patients who are concomitantly taking PPAR-gamma agonists (Thiazolidinediones) due to the increased risk of fluid retention which may exacerbate to heart failure. Frequent clinical monitoring is advised in such patients. Report any unusual symptoms to the doctor on priority. Do not stop the use of any medicine without consulting your doctor.

• Single Person Use

  This medicine (pen) should not be shared with others even if the needle is changed.

• Driving or Operating machinery

  This medicine may cause symptoms such as blurred vision, dizziness, inability to concentrate etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating heavy machinery if you experience any of these symptoms during treatment with this medicine.

Carefully follow all the instructions given by your doctor. Do not administer in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Do not stop the use of this medicine without consulting your doctor. Close monitoring of blood glucose levels and frequent follow-up visits with the doctor may be required based on the clinical condition. Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• May cause sleepiness

• dailymed - insulin detemir [Internet]. Available from: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d38d65c1-25bf-401d-9c7e-a2c3222da8af [cited 2/6/2021]. 2020